Lung Cancer Clinical Trials in Boulogne-Billancourt
5 recruitingBoulogne-Billancourt, France
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Mirati Therapeutics Inc.806 enrolled764 locationsNCT04613596
Recruiting
Phase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-small Cell Lung Cancer (NSCLC)
Amgen750 enrolled379 locationsNCT05920356
Recruiting
Not Applicable
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
Metastatic Lung Cancer
Institut Curie300 enrolled3 locationsNCT04790682
Recruiting
Not Applicable
Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
Lung Cancer
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT04300062
Recruiting
Phase 1Phase 2
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
NSCLC (Advanced Non-small Cell Lung Cancer)Stage IV Lung Cancer
Inhatarget Therapeutics32 enrolled15 locationsNCT06896890